Iterum Therapeutics (ITRM) Earnings Date & Reports

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

ITRM is expected to report earnings to rise 25.00% to -15 cents per share on May 09

Iterum Therapeutics ITRM Stock Earnings Reports

Q1'25

Est.

$-0.15

Q4'24

Beat

by $0.10

Q3'24

Missed

by $0.06

Q2'24

Beat

by $0.15

Q1'24

Beat

by $0.33

The last earnings report on February 07 showed earnings per share of -11 cents, beating the estimate of -21 cents. With 383.52K shares outstanding, the current market capitalization sits at 44.96M.

View a ticker or compare two or three

Compare

ITRM